Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2024

Jun 10, 2024

30071_dirs_2024-06-10_b03d5d55-214a-476d-be67-0048522f6f7d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-06-04

Reporting Person: Rider Michael J (Global General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-06-04 ResMed Common Stock F 267.244 $206.33 Disposed 6444 Direct

Footnotes

F1: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023.

F2: Includes 103.91 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan.